Safety Profiles of Newer Contraceptives presented at meeting of Society of Reproductive Investigation

RSI Chief Medical Officer, Dr. Donald R. Mattison, in collaboration with colleagues from the Institute for Safe Medication Practices and Wake Forest University, evaluated and compared the safety profiles of newer contraceptives using 43,324 adverse event case reports submitted to the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS), for the two years ending July 2017.  The presentation on Saturday, March 10, 2018 in San Diego described the strong safety profiles of the newer contraceptives, as well as issues of concern.

For more details see the presentation poster here.

 

Posted in

More RSI News

Dr. Mattison chairs NAM report

July 24, 2020
National Academy of Sciences review chaired by Dr. Mattison

Compounded medications prepared by pharmacists or physicians have been used extensively throughout history as a mainstay of therapeutics.  Over the past half-century – with the…

Read News Item

COVID-19 timeline by RSI

May 23, 2020
Screen grab of RSI's Covid-19 timeline

As part of its new Risk & Crisis Communication Master Class & Boot Camp, and its ongoing commitment to keep its understanding of major public…

Read News Item

Country Foods Forum

March 1, 2020
Cover of Health Canada, RSI-organized, Country Foods Forum highlights

Leading up to February 11 and 12, 2020, Risk Sciences International had the privilege of assisting Health Canada in its organization of the Country Foods…

Read News Item

Workshop on Evidence Integration December 5-6, 2019

November 11, 2019
RSI logo in white

Risk Sciences International is organizing a two day Workshop on Evidence Integration in support of human health risk assessment in collaboration with the McLaughlin Centre…

Read News Item